Linknew Capital
联新资本
Linknew Capital (联新资本) is a China-based venture capital fund with a track record in both technology and healthcare investments. The fund has backed automotive chip designer Yuntu Semiconductor across multiple rounds, including a Series A+ in 2022 and a B2 round in 2024, alongside industrial investors like Xiaomi's investment arm and BAIC Capital . It also participated in early funding for Aikai Biotech in 2022, joining 5Y Capital and other firms in backing the biotech startup . elsewhere's corpus does not contain detailed information on Linknew Capital's founding, fund size, or full investment strategy beyond these disclosed deals.
AI-generated — may contain errors, please verify.
Coverage
Yunqi Capital Portfolio | Seed Round Lead Investment Project *Magic Shape Intelligence* Completes Hundreds of Millions of RMB in Pre-A Funding: Accelerating Construction of "Token Super Factory"
Supplying High-Quality Tokens for the AGI Era
ZhenFund angel project "Future Not Far" closes 200 million yuan angel round, pioneering consumer-grade deployment of general-purpose home robots
The funds will be primarily used for product iteration of general-purpose home robots and enhancements to core algorithms and system capabilities.
BlueRun Ventures | Yuntu Semiconductor Closes Hundreds of Millions of RMB in B2 Round
Paths to High-Quality, Commercially Viable Development of Domestic Chips
BlueRun Ventures July Report | The Beginning of Lucky Charms
Launching H2 Exploration
"Yuntu" Closes Hundreds of Millions of RMB in Series A+ Funding to Build Full Lineup of Premium Automotive-Grade Chips | BlueRun Ventures
Filling the gap in China's automotive-grade mid-to-high-end MCU market
April: Imagination Is the Courage with Which We Face the World | 5Y News Monthly
The big news from last month.
5Y News | Aikai Biotech Completes Three Funding Rounds in Its First Year
Innovate from the source.
